4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
13112
Alzheimer's Disease Biomarker Evaluation By Sers-based Immunoassay In Shsy-5y Cell Line
Part of Topic
Virtual
•Alzheimer's disease is characterized by the accumulation of amyloid-β and tau, which precede clinical symptoms.
•Early and accurate biomarker detection is crucial for improving diagnosis and treatment outcomes.
•APP- and tau-overexpressing cell models were used to evaluate biomarker expression using ELISA, WB, and SERS.
•The analytical performance of SERS was compared with ELISA for biomarker quantification.
Comments
Email is required but is not shown publicly.
Loading comments...